Health Catalyst (HCAT) Receivables (2018 - 2026)

Health Catalyst's Receivables history runs 9 years deep, the most recent figure standing at $65.6 million for Q1 2026.

• Quarterly Receivables fell 8.5% year-over-year to $65.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.6 million (down 8.5% YoY) and the FY2025 annual result came in at $69.2 million, changed 0.36% from the prior year.
• Receivables was $65.6 million for Q1 2026 at Health Catalyst, down from $69.2 million in the prior quarter.
• Across five years, Receivables topped out at $77.1 million in Q2 2025 and bottomed at $43.3 million in Q1 2022.
• A 5-year average of $60.1 million and a median of $61.4 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables surged 46.7% — and 2024, when it declined 9.74%.
• Health Catalyst's Receivables stood at $48.9 million in 2022, then soared by 32.99% to $65.0 million in 2023, then rose by 6.14% to $69.0 million in 2024, then gained by 0.36% to $69.2 million in 2025, then slipped by 5.17% to $65.6 million in 2026.
• Business Quant data shows HCAT's Receivables at $65.6 million in Q1 2026, $69.2 million in Q4 2025, and $68.6 million in Q3 2025.